A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487854A2 Novel isoforms of vascular endothelial ell growth inhibitor
12/22/2004	EP1487852A1 Anti-protozoal vaccine
12/22/2004	EP1487826A1 New crystalline forms of (2s)-n-5- amino(imino)methyl -thienylmethyl-1-(2r)-2- (carboxymethyl)amino -3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
12/22/2004	EP1487541A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/22/2004	EP1487492A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
12/22/2004	EP1487491A2 Novel of cytokine inhibitors
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487487A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487481A2 Methods of treating nerve entrapment syndromes
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487478A2 Interferon beta-like molecules for treatment of stroke
12/22/2004	EP1487477A2 Methods of using flt3-ligand in immunization protocols
12/22/2004	EP1487476A1 Use of angiotensin 1-7 for enhancing cardiac function
12/22/2004	EP1487475A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
12/22/2004	EP1487473A2 Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487463A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors
12/22/2004	EP1487462A2 Preparations for topical skin use and treatment
12/22/2004	EP1487459A1 Peptide analogues and uses thereof
12/22/2004	EP1487426A2 Methods of inducing terminal differentiation
12/22/2004	EP1487416A2 Drug microparticles
12/22/2004	EP1487412A1 Chemosensitizing with liposomes containing oligonucleotides
12/22/2004	EP1487411A2 Inhalable sustained therapeutic formulations
12/22/2004	EP1487410A2 Preparation of sterile stabilized nanodispersions
12/22/2004	EP1487406A1 Heat-reversible composition treating hyposalia and asialia
12/22/2004	EP1487285A1 Alertness bar
12/22/2004	EP1487268A2 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
12/22/2004	EP1363656B1 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1311284B1 Saratin for inhibiting platelet adhesion to collagen
12/22/2004	EP1226230B1 Lactobacillus helveticus producing antihypertensive di- and tripeptides
12/22/2004	EP1210103B1 Thrombopoietin for treatment of neurologic damage
12/22/2004	EP1196027A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1119344B1 Method for prevention and/or cosmetic treatment of skin stripe and use in dermatology
12/22/2004	EP0918535B1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
12/22/2004	EP0862584B1 Production of antibodies
12/22/2004	EP0817648B1 Vascular endothelial cell growth factor antagonists
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	EP0786005B1 Compositions for treatment of coronary artery diseases using gene therapy.
12/22/2004	EP0768889B1 Cancer therapy using lymphotoxin
12/22/2004	EP0749441B1 Expression and purification of cloned human alpha-fetoprotein
12/22/2004	EP0658200B1 Glucagon receptors
12/22/2004	EP0598717B2 Duplex printer
12/22/2004	CN1556863A Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556828A Hydrophili polymer derirative having Y shaped branch, its preparation method, combined object with medicine molecule and medical compositon containing combined object
12/22/2004	CN1556816A Application of cardiokinetic hormone in liver disease
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556711A Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
12/22/2004	CN1556710A Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
12/22/2004	CN1556701A Tetrapeptide derivative crystals
12/22/2004	CN1556693A Medicine for preventing and treating bromidrosis
12/22/2004	CN1556220A Antigen polypeptide of IC53 gene product, use of automatibody in diagonosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide
12/22/2004	CN1555886A Brilliant bingruilin acetate solid lipid nano particle oral preparation and its preparation method
12/22/2004	CN1555885A Application of leukin 1 acceptor antagonist in medicine for preventing and treating posterior cataract
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181199C Lichenized bacillus L-25 keratinase and its encoding DNA
12/22/2004	CN1181099C Anticoagulation and thrombolytic thrombus target fusion mA5UKB
12/22/2004	CN1181096C Cyclic hexapeptide somatostatin analogues
12/22/2004	CN1181094C Hemopoiesis factor and its application
12/22/2004	CN1181092C Conjugates useful in treatment of prostate cancer
12/22/2004	CN1181091C Factor Xa inhibitors
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004	CN1180842C Slow releasing microballoon injection of fish mature accelerating hormone and its prepn process
12/22/2004	CN1180841C Method to enhance healing of sternum after sternotomy
12/22/2004	CN1180840C Cyclosphorin-containing soft capsule preparation
12/22/2004	CN1180839C Powdery preparation containing polymeric medicine for mucosal administration
12/21/2004	US6833448 Annexin derivatives with endogenous chelation sites
12/21/2004	US6833439 IP-10/MIG receptor designated CXCR3, nucleic acids and methods of use therefor
12/21/2004	US6833438 Involves STEAP (six transmembrane epithelial antigen of the prostate); used in diagnosis, therapy and management of various cancers, including prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer
12/21/2004	US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833435 Compositions isolated from bovine tissues and methods for their use
12/21/2004	US6833382 Streptogramins and method for preparing same by mutasynthesis
12/21/2004	US6833362 Method and composition for the accelerated in vivo removal of ethanol
12/21/2004	US6833358 Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
12/21/2004	US6833357 Compositions and methods for modulating muscle cell and tissue contractility
12/21/2004	US6833355 Use of protein H as cytostatic agent
12/21/2004	US6833354 Agent for the treatment of bone diseases
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004	US6833352 Coagulation factor Viia composition
12/21/2004	US6833351 Administering Erythropoetin or a vector that expresses EPO in vivo, concomitantly or sequentially or via co- administration with the RBV or with the RBV and IFN.
12/21/2004	US6833349 Therapy for skin disorders; psoriasis
12/21/2004	US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004	US6833256 Interferon tau mutants and methods for making them
12/21/2004	US6833253 Nucleotide sequences coding polypeptides for use in the prevention of microorganismal infections
12/21/2004	US6833248 Polypeptides; culture product
12/21/2004	US6833247 Comprises polynucleotide sequences for diagnosing, monitoring, prognosticating, preventing or treating tumors; drug screening; molecular markers
12/21/2004	US6833243 For diagnosis of psychosis/schizophrenia via detection of mutant allele
12/21/2004	US6833241 Mammary gland chemokine
12/21/2004	US6833239 Methods to identify modulators of FKHL7 DNA-binding activity
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	US6833131 Antivenom immunesera
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004	CA2227241C Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

1 ... 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 ... 3163